The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588Massimiliano Cazzaniga, Alexander Bertuccioli, Marco Cardinali et al.|Microorganisms|2024Cited by 15
The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-RadiotherapyMassimiliano Cazzaniga, Alexander Bertuccioli, Marco Cardinali et al.|International Journal of Molecular Sciences|2024Cited by 13
Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapyMassimiliano Cazzaniga, Alexander Bertuccioli, Giordano Bruno Zonzini et al.|Pathology & Oncology Research|2023Cited by 9
Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional StudyFrancesco Di Pierro, Nicola Zerbinati, N. Memon et al.|Microorganisms|2025Cited by 8
Effects of Melissa officinalis Phytosome on Sleep Quality: Results of a Prospective, Double-Blind, Placebo-Controlled, and Cross-Over StudyFrancesco Di Pierro, Nicola Zerbinati, Davide Sisti et al.|Nutrients|2024Cited by 8